Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis-opioid interaction in fibromyalgia pain
2019-001861-33Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Bediol Cannabis Flos and oxycodone in fibromyalgia (FM) (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Composite side effects score. Started May 2019; status: completed.
02
Drugs
Bediol Cannabis Flosoxycodone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2019-001861-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001861-33.